Roche Xolair gets USFDA nod for children, adults with one or more food allergies
Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Xolair (omalizumab) for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure to one or more foods in adult and paediatric patients aged 1 year and older with IgE-mediated food allergy. People taking Xolair for food allergies […]